HIV infection and liver transplantation: A review of the literature

British Columbia Medical Journal

Volumn 46, Issue 1, 2004, Pages

  Braitstein, Paula ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Brit Columbia Ctr E   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PEGINTERFERON; REBETRON; TSUKUBAENOLIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CAUSE OF DEATH; DRUG METABOLISM; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LITERATURE; LIVER FAILURE; LIVER METABOLISM; LIVER TOXICITY; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 19644372937     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Hogg RS, Yip B, Kully C, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 1999;160:659-665.
2. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: The EuroSIDA study. Lancet 2000;356:291-296.
3. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
4. Puoti M, Gargiulo F, Roldan EQ, et al. Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. J Infect Dis 2000;181:2033-2036.
5. Sulkowski MS, Thomas DL, Chaisson RE, et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B infection. JAMA 2000;283:74-80.
6. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-497.
7. Neff G, Jayaweera D, Tzakis A. Liver transplantation for HIV-infected patients with end-stage liver disease. Current Opinion in Organ Transplantation 2002;7:114-123.
8. Soriano V, Garcia-Samaniego J, Valencia E, et al. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 1999;15:1-4.
9. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: Lessons from the Vancouver Injecting Drug Users Study. AIDS 1997;11:F59-F65.
10. Braitstein P, Montessori V, Montaner JSG, et al. Hepatitis C is an independent predictor of mortality among a population-based treatment cohort of antiretroviral naive individuals initiating triple-combination therapy [abstract 160]. Can J Infectious Diseases 2003;14(suppl A):28A.
11. Martin-Carbonero L, Soriano V, Valencia E, et al. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res Hum Retroviruses 2001;17:1467-1471.
12. Soriano V, Martin-Carbonero L, Garcia-Samaniego J, et al. Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus [comment]. Clin Infect Dis 2001;33:1793-1795.
13. Rubin RH, Jenkins RL, Shaw BW Jr, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987;44:1-4.
14. Mullen MA, Kohut N, Sam M, et al. Access to adult liver transplantation in Canada: A survey and ethical analysis. CMAJ 1996;154:337-342.
15. Tzakis AG, Cooper MH, Dummer S, et al. Transplantation in HIV+ patients. Transplantation 1990;49:354-358.
16. Ragni M, Bontempo F, Lewis J. Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med 1990;322:1886-1887.
17. Ahuja T, Zingman B, Glicklich D. Long-term survival in an HIV-infected renal transplant recipient. Am J Nephrol 1997;17:480-482.
18. Bouscarat F, Samuel D, Simon F, et al. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994;19:854-859.
19. Jacobson S, Calne R, Wreghitt T. Outcome of HIV infection in transplant patient on cyclosporin. Lancet 1991;337:794.
20. Vanhems P, Bresson-Hadni S, Vuitton DA, et al. Long-term survival without immunosuppression in HIV-positive liver-graft recipient. Lancet 1991;337(8733):126.
21. Roland M, Carlson L, Ragni M, et al. Solid organ transplantation in HIV-infected recipients: A review of 53 cases in the HAART-era. Presented at: International AIDS Conference, 2002. Barcelona, Spain.
22. Ragni MV, Dodson SF, Hunt SC, et al. Liver transplantation in a hemophilia patient with acquired immunedeficiency syndrome. Blood 1999;92:1113.
23. Gow PJ, Mutimer D. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy. AIDS 2001;15:291-292.
24. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001;72:1684-1688.
25. Nowak P, Schvarcz R, Ericzon BG, et al. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2003;19:13-19.
26. Sugawara Y, Makuuchi M, Morisawa Y, et al. Living donor liver transplantation in a patient with HIV. Nippon Rinsho. Japanese J Clin Med 2002;60:803-806.
27. Purgus R, Tamalet C, Poignard P, et al. Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient. Transplantation 1998;66:1384-1386.
28. Berenguer M, Prieto M, Rayon JM, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatolgy 2000;32:852-858.
29. Feray C, Caccamo L, Alexander GJM, et al. European Collaborative Study on Factors Influencing Outcome after Transplantation for Hepatitis C. Gastroenterology 1999;117:619-625.
30. Ghobrial RM, Farmer DG, Baquerizo A, et al. Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999;229:824.
31. Pelletier SJ, Raymond DP, Crabtree TD, et al. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology 2000;32:375-381.
32. Pelletier SJ, Raymond DP, Crabtree TD, et al. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 2000;32:418-426.
33. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.
34. Kuo P, Stock P. Transplantation in the HIV+ patient. Am J Transplantation 2001;1:13-17.
35. Tolan D, Davies M, Millson C. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001;345:1781.
36. Sheikh AM, Wolf DC, Lebovics E, et al. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation 1999;68:307-309.
37. Schvarz R, Rudbeck G, Soderdahl G, et al. Interaction between nelfinavir and tacrolimus after orthotopic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation 2000;69:2194-2195.
38. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003;75:425-429.
39. Nair S, Eustace J, Thuluvath P. Effect of race on outcome of orthotopic liver transplantation: A cohort study. Lancet 2002;359:287-293.
40. Policy 4.0: Acquired Immune Deficiency Syndrome (AIDS) and Human Pituitary Derived Growth Hormone (HPDGH) and Human T-Lymphotropic Virus Type (HTLV-1). United Network of Organ Sharing (UNOS) Resources: Policies www.unos. org/policiesandbylaws/policies.asp?resources=true (24 June 1992: retrieved 1 December 2003).
41. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. Atlanta, GA:United States Public Health Service, 2001.
42. Halpern S, Ubel P, Caplan A. Solid organ transplantation in HIV-infected patients. N Engl J Med 2002;347:284-287.